IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,712 | +326.2% | 96,703 | +110.6% | 0.04% | +500.0% |
| Q2 2023 | $871 | +71.8% | 45,908 | +40.4% | 0.01% | +16.7% |
| Q1 2023 | $507 | +35.9% | 32,700 | +55.5% | 0.01% | +20.0% |
| Q4 2022 | $373 | -99.6% | 21,027 | +25.9% | 0.01% | +400.0% |
| Q3 2022 | $93,000 | +5.7% | 16,704 | -26.2% | 0.00% | 0.0% |
| Q2 2022 | $88,000 | -31.2% | 22,622 | +50.5% | 0.00% | 0.0% |
| Q4 2021 | $128,000 | -46.9% | 15,032 | -45.8% | 0.00% | 0.0% |
| Q3 2021 | $241,000 | -83.4% | 27,749 | -69.3% | 0.00% | -87.5% |
| Q1 2021 | $1,451,000 | +621.9% | 90,479 | +1978.5% | 0.01% | +700.0% |
| Q4 2020 | $201,000 | -19.0% | 4,353 | -38.2% | 0.00% | -50.0% |
| Q3 2020 | $248,000 | -2.4% | 7,042 | -32.4% | 0.00% | 0.0% |
| Q2 2020 | $254,000 | – | 10,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |